Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estradiol for gonadotropin secretion in PCOS
NCT03401047Phase 1Recruiting
- Sponsor
- University of Virginia
- Start
- Nov 2017
- Primary completion
- Oct 2025
- Modality
- Hormone, Biologic
- Countries
- 1
01
Overview
Phase 1, open-label trial of estradiol in polycystic ovary syndrome (PCOS) (2 arms), sponsored by University of Virginia. Primary endpoint: Estradiol-induced change in 24-hour urinary LH excretion at 7 days. Started Nov 2017; status: recruiting.
02
Drugs
estradiol
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT03401047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03401047.